Key Financial Data Of Reporting Company

D.Western Therapeutics Institute, Inc. - Filing #7735821

Concept As at
2017-06-30
2017-04-01 to
2017-06-30
2017-01-01 to
2017-06-30
2016-01-01 to
2016-12-31
As at
2016-12-31
As at
2016-06-30
2016-01-01 to
2016-06-30
2016-04-01 to
2016-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
79,107,000 JPY
168,002,000 JPY
96,076,000 JPY
Ordinary profit (loss)
-307,505,000 JPY
-304,463,000 JPY
-137,707,000 JPY
Net assets
2,448,780,000 JPY
2,877,260,000 JPY
3,044,936,000 JPY
Total assets
3,241,545,000 JPY
2,912,795,000 JPY
3,077,467,000 JPY
Basic earnings (loss) per share
-44.43
-50.98
-10.46
-4.73
-3.05
Diluted earnings per share
Equity-to-asset ratio
0.719 xbrli:pure
0.935 xbrli:pure
0.931 xbrli:pure
Net cash provided by (used in) operating activities
-417,701,000 JPY
-333,558,000 JPY
-140,602,000 JPY
Net cash provided by (used in) investing activities
-1,043,322,000 JPY
-230,797,000 JPY
-297,889,000 JPY
Net cash provided by (used in) financing activities
1,406,969,000 JPY
1,066,537,000 JPY
1,066,537,000 JPY
Cash and cash equivalents
2,228,163,000 JPY
2,291,934,000 JPY
2,390,828,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.